Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIP

Summary

Checkpoint inhibitor-related pneumonitis (CIP）is a common fatal immune-related adverse event of PD-1/PD-L1 inhibitors. Some CIP patients have poor effect on hormone therapy, and the remission time of CIP varies greatly. Antifibrotic drugs may be effective in patients with CIP.

Timeline

Start

2021-10-10

Primary completion

2023-10-20

Completion

2024-10-20

Drugs

Indications